Abstract P6-18-35: A phase 1 study of erlotinib and metformin in advanced triple negative breast cancer
Keyword(s):
Phase 1
◽
2018 ◽
Vol 171
(1)
◽
pp. 111-120
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. 1011-1011
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. e12070-e12070
◽
2017 ◽